Cardiac Rhythm Management Devices | Market Insights | Asia Pacific | 2022
The COVID-19 global pandemic will have a significant impact on the Asia Pacific CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery, the market will grow through 2030 driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM device in the Asia Pacific region across an 11-year period.
